Target intelligence / Profile preview

Nuclear protein, transcriptional regulator, 1-like, pseudogene

Molecular classification
Pseudogene, Long non-coding RNA (lncRNA)
01

Overview

ENSG00000270405 is a human pseudogene named nuclear protein, transcriptional regulator, 1-like, pseudogene. Pseudogenes are segments of DNA that resemble protein-coding genes but contain mutations or truncations that prevent them from encoding functional proteins[1][5]. While pseudogenes can sometimes produce long non-coding RNAs (lncRNAs) that regulate parental gene expression through various mechanisms (e.g., microRNA sponging, antisense regulation), there is currently no evidence for specific biological or disease roles for this locus, and no known drug interactions or biomarker relevance[3][4][5]. It is not a functional protein nor a traditional drug target. Summary: This entry is a pseudogene, not a protein-coding gene or therapeutic target. It may be transcribed as a non-coding RNA with potential but unproven regulatory roles; it is not a druggable target, nor currently associated with any disease or biomarker use[3][5].

Other names
AC104692.2lnc-GALNT11-6GC07P152063
02

Biological functions

Other (pseudogenes may exert regulatory roles such as acting as competitive endogenous RNAs or microRNA sponges through their RNA transcripts, but no specific function is attributed to this locus)
03

Disease associations

Other (pseudogenes, in general, can play roles in gene regulation or be associated with disease when their RNA products affect parental genes, but no disease association is reported for this specific pseudogene)

Beyond the preview

Go deeper on Nuclear protein, transcriptional regulator, 1-like, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear protein, transcriptional regulator, 1-like, pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call